During the past decade, Centre National de Transfusion Sanguine conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre National de Transfusion Sanguine" #1 collaborator was "Institut National de la Santé Et de la Recherche Médicale, France" with 2 trials as a collaborator, "University of Paris 5 - Rene Descartes" with 1 trials as a collaborator and "laboratory of excellence GR-Ex" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Centre National de Transfusion Sanguine" are "Sickle Cell Disease" (2 trials) and "Sickle Cell Anemia" (1 trials). Many other conditions were trialed in "Centre National de Transfusion Sanguine" in a lesser frequency.

Most popular intervention types in "Centre National de Transfusion Sanguine" are "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "biological analysis" (1 trials) and "peripheral arterial tonometry" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre National de Transfusion Sanguine" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centre National de Transfusion Sanguine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centre National de Transfusion Sanguine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre National de Transfusion Sanguine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".